These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Antiphospholipid syndrome and systemic lupus erythematosus: are they separate entities or just clinical presentations on the same scale? Shoenfeld Y; Meroni PL; Toubi E Curr Opin Rheumatol; 2009 Sep; 21(5):495-500. PubMed ID: 19593144 [TBL] [Abstract][Full Text] [Related]
4. Lupoid sclerosis: what is the role of antiphospholipid antibodies? Lima I; Melo A; Brandi IV; Costa O; Santiago M J Clin Rheumatol; 2007 Apr; 13(2):85-6. PubMed ID: 17414536 [TBL] [Abstract][Full Text] [Related]
5. Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care. Choi MY; Barber MR; Barber CE; Clarke AE; Fritzler MJ Lupus; 2016 Jul; 25(8):838-49. PubMed ID: 27252260 [TBL] [Abstract][Full Text] [Related]
7. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive. Giles I; Rahman A Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782 [TBL] [Abstract][Full Text] [Related]
9. Sole existence of antithrombin antibody in patients with systemic lupus erythematosus showing tendency of its antigenic determinants directing against exosite II (antithrombin/heparin binding site) of thrombin. Matsuda J; Matsuyama A; Atsumi G; Ohkura N Blood Coagul Fibrinolysis; 2008 Jan; 19(1):66-9. PubMed ID: 18180618 [TBL] [Abstract][Full Text] [Related]
10. Contraception in adolescents with systemic lupus erythematosus. Tincani A; Nuzzo M; Lojacono A; Cattalini M; Meini A Lupus; 2007; 16(8):600-5. PubMed ID: 17711895 [TBL] [Abstract][Full Text] [Related]
11. Longitudinally extensive myelitis in a patient with characteristic autoantibody profile of systemic lupus erythematosus: a challenging etiological diagnosis. Falgàs N; Sola-Valls N; Sepúlveda M; Lapuma D; Ariño H; Llufriu S; Espinosa G; Saiz A Lupus; 2014 Dec; 23(14):1555-6. PubMed ID: 25107937 [No Abstract] [Full Text] [Related]
12. Anetoderma in a systemic lupus erythematosus patient with anti-PCNA and antiphospholipid antibodies. Alvarez-Cuesta CC; Raya-Aguado C; Fernández-Rippe ML; Sánchez TS; Pérez-Oliva N Dermatology; 2001; 203(4):348-50. PubMed ID: 11752829 [TBL] [Abstract][Full Text] [Related]
13. [Systemic lupus erythematosus - Standards in 2015]. Aringer M; Schneider M Dtsch Med Wochenschr; 2014 Sep; 139(37):1813-6. PubMed ID: 25180995 [No Abstract] [Full Text] [Related]
15. European Working Party on systemic lupus erythematosus and European Forum on Antiphospholipid Antibodies: two networks promoting European research on autoimmunity. Cervera R; Tincani A Lupus; 2009 Sep; 18(10):863-8. PubMed ID: 19671783 [No Abstract] [Full Text] [Related]
16. Preventive strategies in systemic lupus erythematosus. Doria A; Arienti S; Rampudda M; Canova M; Tonon M; Sarzi-Puttini P Autoimmun Rev; 2008 Jan; 7(3):192-7. PubMed ID: 18190877 [TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies are common in an infectious environment but do not predict systemic lupus erythematosus. Cainelli F; Betterle C; Vento S Ann Rheum Dis; 2004 Dec; 63(12):1707-8. PubMed ID: 15547107 [No Abstract] [Full Text] [Related]
19. Antinuclear antibodies directed against proliferating cell nuclear antigen are not specifically associated with systemic lupus erythematosus. Vermeersch P; De Beeck KO; Lauwerys BR; Van den Bergh K; Develter M; Mariën G; Houssiau FA; Bossuyt X Ann Rheum Dis; 2009 Nov; 68(11):1791-3. PubMed ID: 19822716 [No Abstract] [Full Text] [Related]
20. [Antiphospholipid autoantibodies--a phenomenon within a new context?]. Dostál C Vnitr Lek; 2004 Apr; 50(4):257-9. PubMed ID: 15214291 [No Abstract] [Full Text] [Related] [Next] [New Search]